| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/04/2009 | WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 06/04/2009 | WO2009038879A3 Stem cell differentiating agents and uses therefor |
| 06/04/2009 | WO2009036068A3 Gambogic amine, a selective trka agonist with neuroprotective activity |
| 06/04/2009 | WO2009035927A3 Bis-cyclyl substituted ureas or amides as soluble epoxide hydrolase inhibitors |
| 06/04/2009 | WO2009035634A3 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| 06/04/2009 | WO2009035527A3 Levonorgestrel crystallization |
| 06/04/2009 | WO2009032749A3 Salicylanilide modified peptides for use as oral therapeutics |
| 06/04/2009 | WO2009030887A3 Bis-aromatic compounds useful in the treatment of inflammation |
| 06/04/2009 | WO2009029801A3 Selective cytopheresis devices and related methods thereof |
| 06/04/2009 | WO2009029087A3 Superporous hydrogels |
| 06/04/2009 | WO2009024590A3 Antifungal composition |
| 06/04/2009 | WO2009022346A3 Phenyl carbamates for treating gastrointestinal inflammation |
| 06/04/2009 | WO2009022339A9 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 06/04/2009 | WO2009022216A3 Rna sequence motifs in the context of defined internucleotide linkages inducing specific immune modulatory profiles |
| 06/04/2009 | WO2009022179A3 Glucokinase activators in the treatment of osteoarthritis |
| 06/04/2009 | WO2009019503A3 P2x7 antagonists for use in the treatment of mood disorders |
| 06/04/2009 | WO2009016514A3 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva |
| 06/04/2009 | WO2009014789A3 Enveloped virus neutralizing compounds |
| 06/04/2009 | WO2009010448A3 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof |
| 06/04/2009 | WO2009008990A3 Methods and compositions for treatment of cancer and other angiogenesis - related diseases |
| 06/04/2009 | WO2009007687A3 An inhalable medicament |
| 06/04/2009 | WO2009007300A3 Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
| 06/04/2009 | WO2009004427A3 Benzimidazole derivatives |
| 06/04/2009 | WO2008157635A3 Synthetic bile acid composition, method, and preparation |
| 06/04/2009 | WO2008156817A3 Renin inhibitors |
| 06/04/2009 | WO2008155669A3 Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases |
| 06/04/2009 | WO2008147245A3 Controlled release proxodolol pharmaceutical composition |
| 06/04/2009 | WO2008143880A3 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and traumatic brain injury |
| 06/04/2009 | WO2008142482A3 Omega-3 lipid compounds |
| 06/04/2009 | WO2008139262A3 Oligoribonucleotides and uses thereof |
| 06/04/2009 | WO2008138459A3 Aqueous pharmaceutical preparation |
| 06/04/2009 | WO2008137054A3 Composition for transmucosal delivery of polypeptides |
| 06/04/2009 | WO2008134048A3 Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| 06/04/2009 | WO2008129256A3 Hiv therapy |
| 06/04/2009 | WO2008125828A3 Oligo-guluronate and galacturonate compositions |
| 06/04/2009 | WO2008122613A3 Food supplement containing alpha-keto acids |
| 06/04/2009 | WO2008121604A3 Compositions and methods for inhibiting expression of a gene from the ebola |
| 06/04/2009 | WO2008101195A4 Drug resistance reversal in neoplastic disease |
| 06/04/2009 | WO2008059370A8 Substituted bicyclocarboxyamide compounds |
| 06/04/2009 | WO2008017604A3 Sandalwood aroma receptors |
| 06/04/2009 | WO2008007227A3 Method and compositions for relieving menopausal and perimenopausal symptoms |
| 06/04/2009 | WO2006101740A3 Compounds having activity in correcting mutant-cftr processing and uses thereof |
| 06/04/2009 | WO2006012586A3 Modulation of fiaf and the gastrointestinal microbiota |
| 06/04/2009 | WO2002026104A3 A combination of appetite controlling agents which create a synergy and produce a satiating result |
| 06/04/2009 | WO2001060458A3 Inhibitors of prenyl-protein transferase |
| 06/04/2009 | US20090144841 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications |
| 06/04/2009 | US20090144839 Methods and compositions for detecting and treating retinal diseases |
| 06/04/2009 | US20090143766 Hydroxyphenyl cross-linked macromolecular network and applications thereof |
| 06/04/2009 | US20090143762 Methods and Compositions for Enhancing the Viability Of Microneedle Pores |
| 06/04/2009 | US20090143761 Agent delivery system and uses of same |
| 06/04/2009 | US20090143583 Transfection reagents |
| 06/04/2009 | US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof |
| 06/04/2009 | US20090143577 Purification of progesterone receptor modulators |
| 06/04/2009 | US20090143571 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 06/04/2009 | US20090143484 Use of garlic oil to increase bioavailability of coenzyme q-10 |
| 06/04/2009 | US20090143483 Therapeutic or preventive drug for osteoporosis comprising isotaxiresinol derived from taxus yunnanensis |
| 06/04/2009 | US20090143480 for improving feed efficiency and muscle-to-fat ratio in animals; side effect reduction |
| 06/04/2009 | US20090143479 Pharmaceutical compositions comprising terbinafine |
| 06/04/2009 | US20090143475 Bronchodilating beta-agonist compositions and methods |
| 06/04/2009 | US20090143474 Reduced dose intravenous acetaminophen |
| 06/04/2009 | US20090143473 Use of inhibitors of the cellular na+/h+ exchanger (nhe) for preparing a medicament for normalizing serum lipids |
| 06/04/2009 | US20090143472 2-tritylamino-3-(hydroxy or methoxy)propionic acid, or corresponding benzylamide thereof as chemical intermediate; chirally pure lacosamide; high purity |
| 06/04/2009 | US20090143471 Process for the Atomization of Ioxilan |
| 06/04/2009 | US20090143470 Invisible Antimicrobial Glove and Hand Antiseptic |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143468 Pet food compositions and methods |
| 06/04/2009 | US20090143467 Anticancer agents based on regulation of protein prenylation |
| 06/04/2009 | US20090143466 Isolation of Atraric Acid, Synthesis of Atraric Acid Derivatives, and Use of Atraric Acid and the Derivatives Thereof for the Treatment of Benign Prostatic Hyperplasia, Prostate Carcinoma and Spinobulbar Muscular Atrophy |
| 06/04/2009 | US20090143464 Method for preventing and/or treating peripheral Neuropathies induced by the administration of an anticancer agent |
| 06/04/2009 | US20090143463 Therapeutic Agent and Treatment Method for Ameliorating Uremia |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143461 Substituted cyclopentanes having prostaglandin activity |
| 06/04/2009 | US20090143460 Novel polymorphic form of rotigotine and process for production |
| 06/04/2009 | US20090143459 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 06/04/2009 | US20090143458 Use of ace inhibitors and/or angiostensin ii receptor antagonists for the improving and/or maintaining the skin tone and for the treatment of skin ageing |
| 06/04/2009 | US20090143457 Polycyclic compounds for use in treating ocular neurodegenerative diseases |
| 06/04/2009 | US20090143456 Polyamine Analogs as Modulators of Cell Migration and Cell Motility |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143453 Methods for treating degenerative diseases/injuries |
| 06/04/2009 | US20090143451 Compounds that increase telomerase reverse transcriptase (tert) expression and methods for using the same |
| 06/04/2009 | US20090143450 Method for treating central pain syndrom or for inducing centrally generated pain in an animal model |
| 06/04/2009 | US20090143449 Bi-Aryl or Aryl-Heteroaryl Substituted Indoles |
| 06/04/2009 | US20090143448 New aminothiazoles as fbpase inhibitors for diabetes |
| 06/04/2009 | US20090143446 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
| 06/04/2009 | US20090143445 HDAC Inhibitors |
| 06/04/2009 | US20090143444 Acid secretion inhibitor |
| 06/04/2009 | US20090143442 Thiazolidinedione analogues |
| 06/04/2009 | US20090143441 Combination therapies of Thiazolidinedione analogues |
| 06/04/2009 | US20090143440 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143439 New pyridines as fbpase inhibitors for treatment of diabetes |
| 06/04/2009 | US20090143438 Novel Pyridine Derivative Having Anti-Helicobacter Pylori Activity |
| 06/04/2009 | US20090143437 Ep4 receptor antagonists |
| 06/04/2009 | US20090143436 Anesthetic composition, formulation and method of use |
| 06/04/2009 | US20090143435 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 06/04/2009 | US20090143434 Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals |
| 06/04/2009 | US20090143433 Cocktail for modulation of alzheimer's disease |
| 06/04/2009 | US20090143432 Synthesis of deuterated catechols and benzo[D][1,3]dioxoles and derivatives thereof |
| 06/04/2009 | US20090143430 Erythropoietin production accelerator |
| 06/04/2009 | US20090143429 Quinoline Derivatives as Neurokinin Receptor Antagonists |
| 06/04/2009 | US20090143428 Quinoline Derivatives 057 |